Meeting
2024 ASCO Gastrointestinal Cancers Symposium
The role of pre-operative ctDNA in resectable intrahepatic cholangiocarcinoma.
Authors
Woo Jin Choi
University of Toronto, Toronto, ON, Canada
Woo Jin Choi , Zhihao Li , Christian Magyar , Antony Tin , Erik Spickard , Himanshu Sethi , Minetta C. Liu , Roxana Bucur , Robert C Grant , Arndt Vogel , Jennifer J. Knox , Geoffrey Liu , Steven Gallinger , Gonzalo Sapisochin , Grainne M. O'Kane
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 528)
DOI
10.1200/JCO.2024.42.3_suppl.528
Abstract #
528
Poster Bd #
E15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Non-invasive minimal residual disease detection of liver cancer using circulating tumor DNA features and α-fetoprotein: A prospective study.
First Author: Yinyin Chang
Poster
2024 ASCO Annual Meeting
Use of cell-free DNA from ascites to identify variants and tumour evolution in a cohort of patients with advanced ovarian cancer.
First Author: Bonnita Werner
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic value of circulating tumor DNA (ctDNA) testing in patients (pts) with rectal cancer after neoadjuvant therapy (NAT) and surgery.
First Author: Sakti Chakrabarti
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic value of minimal residual disease profiling in resectable hepatocellular carcinoma.
First Author: Jie Hu